N

Nuvation Bio Tech Stack

Clinical-stage oncology company developing targeted cancer therapies

Pharmaceutical Manufacturing New York, NY 51–200 employees Founded 2018 Public Company

Nuvation Bio is a publicly traded oncology company with a lean team (51–200 employees) across four geographic hubs pursuing three distinct therapeutic programs: a ROS1 inhibitor, a brain-penetrant IDH1 inhibitor, and a drug-drug conjugate platform. The tech stack reveals a biotech in operational transition — adopting Veeva (clinical/regulatory standard), NetSuite, and Workday while running on legacy ERP (SAP, Oracle) and enterprise infrastructure (Salesforce, ServiceNow). Hiring acceleration across marketing, data, and research functions, paired with active data-integration and HRIS-implementation projects, signals scaling of clinical operations and patient-engagement capabilities ahead of later-stage trials.

Tech Stack 10 technologies

Core StackWorkday ServiceNow SAP Oracle Salesforce Marketing Cloud Microsoft 365 BeyondTrust TeamViewer

AdoptingNetSuite Workday Veeva

What Nuvation Bio Is Building

◆Challenges

Gaps in platform capabilities
Implementing workday
Audit system capabilities
Sarbanes oxley compliance
Streamlining contract operations workflows
Maintaining audit-ready documentation
Data acquisition roadmap execution
Third-party data integration challenges
Data quality issue remediation
Building new programs from the ground up

▲Active Projects

System integration with anheart
Design software release management process
Implement application support structures using managed services
Digital campaign execution and journey development
Automated omnichannel customer journey optimization
Hrms implementation
Hris reporting and metrics
Data acquisition roadmap
Data integration and implementation
Data cataloging and metadata management

Hiring Activity

Accelerating10 roles · 8 in 30d

Department

Marketing

3

Data

1

Engineering

1

HR

1

Legal

1

Manufacturing

1

Medical

1

Research

1

Seniority

Senior

6

Director

2

Manager

2

Mid

1

Notable leadership hires: Digital Marketing Technology Lead

Company intelligence

Find more companies like Nuvation Bio by tech stack, pain points and active projects

Get started free

About Nuvation Bio

Nuvation Bio is a global oncology company founded in 2018 by David Hung, M.D., and headquartered in New York with additional offices in San Francisco, Boston, and Shanghai. The company is focused on developing targeted therapies for hard-to-treat cancers, with a pipeline of three distinct programs in preclinical or early clinical development. As a public company, Nuvation operates under strict regulatory and compliance frameworks (Sarbanes-Oxley, audit-ready documentation standards). Recent operational focus centers on ERP modernization (Workday implementation), digital marketing and patient-engagement infrastructure, and data architecture to support clinical and commercial scaling.

HeadquartersNew York, NY

Company Size51–200 employees

Founded2018

Hiring MarketsChina, United States

Frequently Asked Questions

What is Nuvation Bio's pipeline?

Three programs: a next-generation ROS1 inhibitor, a brain-penetrant IDH1 inhibitor, and a drug-drug conjugate (DDC) platform for oncology indications.